TP53 and neoplasm: In this context, the studies reported in this paper shed new light on a model mechanism by which TRIM8 protein exerts its anticancer activity through a joint action that provides on one hand the activation of the p53 tumor suppressor role and, on the other, the quenching of the oncogenic activity of the ΔNp63α protein.